Non-alcoholic faty liver disease and liver fibrosis score have an independent relationship with the presence of mitral annular calcification

ERGÜL E., EMLEK N., YILMAZ A. S., ÖZTÜRK M., Aydin C., DURAK H., ...Daha Fazla

INTERNATIONAL JOURNAL OF CARDIOVASCULAR IMAGING, cilt.39, sa.8, ss.1431-1436, 2023 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 39 Sayı: 8
  • Basım Tarihi: 2023
  • Doi Numarası: 10.1007/s10554-023-02858-2
  • Dergi Adı: INTERNATIONAL JOURNAL OF CARDIOVASCULAR IMAGING
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Sayfa Sayıları: ss.1431-1436
  • Anahtar Kelimeler: NAFLD-FS, FIB 4, MAC, CARDIOVASCULAR-DISEASE, QUANTIFICATION, MECHANISMS, MORTALITY, RISK
  • Recep Tayyip Erdoğan Üniversitesi Adresli: Evet

Özet

Non-alcoholic faty liver disease (NAFLD) and liver fibrosis score (FIB 4) are associated with increased mortality from cardiovascular causes. NAFLD and cardiac diseases are different manifestations of systemic metabolic syndrome. In this study, we aimed to reveal the relationship between NAFLD and FIB 4 liver fibrosis scores and mitral annular calcification (MAC). One hundred patients were included in the study. Blood samples and echocardiography measurements were obtained from each subject. The two groups were compared in terms of demographic and echocardiographic characteristics. Thirty-one men and 69 women with a mean age of 48.6 +/- 13.1 years were included in the analysis. The patients were divided into two groups as those with MAC (n = 26) and those without (n = 74). The baseline demographic and laboratory data for the two groups were compared. In the group with MAC (+) age, serum creatinine levels, FIB4 and NAFLD Scores; HL, DM rates, angiotensin converting enzyme (ACE) inhibitor and statin usage rates were higher, with statistical significance. NAFLD and FIB 4 liver fibrosis scores have an independent relationship with MAC.